- £113.22m
- £101.54m
- £32.16m
- 76
- 18
- 44
- 40
REG - Diaceutics PLC - FY 2024 Trading Update - Strong Revenue Growth
AnnouncementREG - Diaceutics PLC - Diaceutics Opens US Headquarters
AnnouncementREG - Diaceutics PLC - New Service Launched & First Contract Signed
AnnouncementREG - Diaceutics PLC - PDMR Dealings & Total Voting Rights
AnnouncementREG - Diaceutics PLC - Holding(s) in Company
AnnouncementREG - Diaceutics PLC - Holding(s) in Company
AnnouncementREG - Diaceutics PLC - Diaceutics Wins New $5.1m Contract
AnnouncementREG - Diaceutics PLC - Holding(s) in Company
AnnouncementREG - Diaceutics PLC - Awarded UK Research Institute Grant Funding of £1m
AnnouncementREG - Diaceutics PLC - Total Voting Rights
AnnouncementREG - Diaceutics PLC - Expansion of US Commercial Activities
AnnouncementREG - Diaceutics PLC - Capital Markets Webinar
AnnouncementREG - Diaceutics PLC Danske Bank A/S - Holding(s) in Company
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/Share Incentive Plan
AnnouncementREG - Diaceutics PLC - Board Change Update
AnnouncementREG - Diaceutics PLC - Issue of Share Options/PDMR Shareholdings
AnnouncementREG - Diaceutics PLC - Cancellation of Share Premium Account
AnnouncementRCS - Diaceutics PLC - Diaceutics Announces Key Leadership Appointment
AnnouncementREG - Diaceutics PLC - Holding(s) in Company
Announcement